Navigation Links
MSM: A ray of hope for arthritis patients

Arthritis is a painful degenerative disease which is affecting a large number of people throughout the world. It is no longer limited to old people even the younger generation is falling prey to this disease.// But there is some good news for those affected.

A recent clinical trial confirmed that Methylsulfonylmethane, or MSM, a naturally occurring sulphur compound, can relieve pain and improve physical function in patients with knee arthritis.

MSM is a popular dietary supplement used to ease a range of illnesses or health conditions such as rheumatoid arthritis, osteoarthritis, fibromyalgia, gout, constipation, allergies, and snoring.

The clinical trial was randomised and a double blind study. Twenty-five arthritic patients were assigned three grams of MSM twice a day for twelve weeks. The patients receiving MSM experienced significant relief in pain and improvements in their physical function compared to the patients receiving a placebo. However, MSM did not improve stiffness or aggravated total symptoms.

The trial was conducted at the Southwest College of Naturopathic Medicine in Tempe, Arizona, and the Arthritis Health Centre in Scottsdale, Arizona.

Source: Annual Meeting: American Association of Naturopathic Physicians
'"/>




Page: 1

Related medicine news :

1. Vedic vibration technology- the new cure for arthritis
2. Tai chi helps arthritis
3. Scios Inc. targets drug giants in arthritis war
4. Periodontitis a common problem in patients with arthritis
5. New device for discerning Osteoarthritis
6. Herbal extract aids in rheumatoid arthritis
7. Osteoarthritis and Estrogen are connected
8. Hyaluronan supplementation therapy for Knee Osteoarthritis
9. Green tea beneficial in preventing osteoarthritis
10. Leech Therapy for Osteoarthritis
11. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: